Other News To Note
Friday, December 21, 2012
• Dendreon Corp., of Seattle, said it sold its immunotherapy manufacturing facility in Morris Plains, N.J., to Novartis Pharmaceuticals Corp., a unit of Basel, Switzerland-based Novartis AG, for $43 million in cash.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.